Case number 1:17-cv-00954
Biogen International GmbH et al v. Zydus Pharmaceuticals (USA) Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 23, 2020 | 22 | USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [20] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc. USCA Case Number 21-1098 (mdb) |
| Oct 22, 2020 | 21 | USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [20] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Case Number 21-1078 (mdb) |
| Oct 20, 2020 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [20] Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. ( Filing fee $505, receipt number ADEDC-3277238.) (Balick, Steven) |
| Oct 20, 2020 | 20 | Notice of Appeal* (1) |
| Oct 20, 2020 | 20 | Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [18] Judgment,,, . Appeal filed by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Oct 20, 2020 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [20] Notice of Appeal (Federal Circuit). (nmg) |
| Oct 20, 2020 | N/A | Appeal Notification to Reporter Gaffigan (0) Docket Text: Notification regarding [20] Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan (nmg) |
| Sep 23, 2020 | 19 | Judgment (3) |
| Sep 23, 2020 | 19 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Judgment)(mdb) |
| Sep 22, 2020 | 18 | Judgment (3) Docket Text: JUDGMENT in favor of Accord Healthcare Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Graviti Pharmaceuticals Inc., Graviti Pharmaceuticals Pvt. Ltd., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Impax Laboratories LLC, Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Slayback Pharma India LLP, Slayback Pharma LLC, TWi Pharmaceuticals Inc., TWi Pharmaceuticals USA Inc., TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Windlas Healthcare Pvt. Ltd., Zydus Pharmaceuticals (USA) Inc. against Biogen International GmbH, Biogen MA Inc. (CASE CLOSED). Signed by Judge Maryellen Noreika on 9/22/2020. (dlw) |
| Nov 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:17-cv-00823-MN through 1:17-cv-00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN through 1:17-cv-00847-MN, 1:17-cv-00849-MN through 1:17-cv-00857-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-00875-MN, 1:17-cv-00954-MN, 1:18-cv-00337-MN, 1:18-cv-00623-MN, 1:18-cv-01361-MN, 1:19-cv-00303-MN, and 1:19-cv-00333-MN (rjb) |
| Feb 2, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00824-LPS et al.(dlb) |
| Feb 2, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-00823-LPS. (ntl) |
| Feb 2, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-00823-LPS. Associated Cases: 1:17-cv-00824-LPS et al. (ntl) |
| Jan 31, 2018 | 17 | Proposed Order (22) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Jan 31, 2018 | 16 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Jan 17, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/17/2018. (Court Reporter B. Gaffigan.) Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Dec 28, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 17, 2018 at 9:30 AM. Plaintiffs counsel shall initiate the teleconference call to 302-573-4571. No further submissions are necessary. ORDERED by Judge Leonard P. Stark on 12/28/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg) |
| Dec 20, 2017 | 14 | Proposed Order (25) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Dec 20, 2017 | 13 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Dec 20, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:17-cv-00824-LPS, 14 in 1:17-cv-00856-LPS, 14 in 1:17-cv-00872-LPS, 14 in 1:17-cv-00848-LPS, 14 in 1:17-cv-00849-LPS, 17 in 1:17-cv-00845-LPS, 16 in 1:17-cv-00846-LPS, 12 in 1:17-cv-00847-LPS, 15 in 1:17-cv-00851-LPS, 15 in 1:17-cv-00823-LPS, 15 in 1:17-cv-00852-LPS, 16 in 1:17-cv-00857-LPS, 16 in 1:17-cv-00828-LPS, 17 in 1:17-cv-00875-LPS, 13 in 1:17-cv-01361-LPS, 19 in 1:17-cv-00825-LPS, 15 in 1:17-cv-00829-LPS, 15 in 1:17-cv-00855-LPS, 17 in 1:17-cv-00827-LPS, 17 in 1:17-cv-00853-LPS, 16 in 1:17-cv-00826-LPS, 15 in 1:17-cv-00874-LPS, 12 in 1:17-cv-00954-LPS, 14 in 1:17-cv-00854-LPS, 17 in 1:17-cv-00850-LPS) STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc. Signed by Judge Leonard P. Stark on 12/20/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg) |
| Dec 15, 2017 | 12 | Stipulation (12) Docket Text: STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Nov 29, 2017 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than December 15, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 11/29/17. Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Oct 24, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andy J. Miller for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Oct 23, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Scott B. Feder for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Oct 23, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Scott B. Feder, Andy J. Miller, Timothy F. Peterson and Jonathan B. Turpin filed by Zydus Pharmaceuticals (USA) Inc. Signed by Judge Leonard P. Stark on 10/23/17. (ntl) |
| Oct 23, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy F. Peterson for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Oct 23, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Gaertner for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Oct 23, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan B. Turpin for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 20, 2017 | 10 | Certification of Jonathan B. Turpin (1) |
| Oct 20, 2017 | 10 | Certification of Andy J. Miller (1) |
| Oct 20, 2017 | 10 | Certification of Scott B. Feder (1) |
| Oct 20, 2017 | 10 | Certification of Michael J. Gaertner (1) |
| Oct 20, 2017 | 10 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Scott B. Feder, Andy J. Miller, Timothy F. Peterson and Jonathan B. Turpin - filed by Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Certification of Michael J. Gaertner, # (2) Certification of Scott B. Feder, # (3) Certification of Andy J. Miller, # (4) Certification of Timothy F. Peterson, # (5) Certification of Jonathan B. Turpin)(Bilson, David) |
| Oct 20, 2017 | 10 | Certification of Timothy F. Peterson (1) |
| Oct 16, 2017 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Oct 16, 2017 | 8 | Answer to Complaint (12) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) |
| Aug 29, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Li Feng for Biogen International GmbH,Li Feng for Biogen International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00872-LPS et al.(lmm) |
| Aug 4, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sanya Sukduang for Biogen International GmbH,Biogen MA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00823-LPS et al.(crb) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney James B. Monroe for Biogen International GmbH and for Biogen MA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00823-LPS et al.(lmm) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew E. Renison for Biogen International GmbH, and for Biogen MA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00823-LPS et al.(lmm) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Li Feng for Biogen MA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00823-LPS et al.(lmm) |
| Jul 28, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] Stipulation Regarding Waiver of Service and Extension of Answer Deadline to October 16, 2017, by Biogen International GmbH, Biogen MA Inc. Signed by Judge Leonard P. Stark on 7/28/2017. (etg) |
| Jul 26, 2017 | 7 | Stipulation (2) Docket Text: STIPULATION Regarding Waiver of Service and Extension of Answer Deadline to October 16, 2017, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Jul 26, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 1:17-cv-00825-LPS, 11 in 1:17-cv-00857-LPS, 8 in 1:17-cv-00824-LPS, 8 in 1:17-cv-00853-LPS, 8 in 1:17-cv-00851-LPS, 8 in 1:17-cv-00829-LPS, 7 in 1:17-cv-00875-LPS, 7 in 1:17-cv-00872-LPS, 8 in 1:17-cv-00873-LPS, 6 in 1:17-cv-00954-LPS, 9 in 1:17-cv-00823-LPS, 9 in 1:17-cv-00856-LPS, 8 in 1:17-cv-00854-LPS, 6 in 1:17-cv-00874-LPS, 8 in 1:17-cv-00852-LPS, 6 in 1:17-cv-00855-LPS, 8 in 1:17-cv-00850-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Sanya Sukduang, Li Feng, and Andrew E. Renison filed by Biogen International GmbH, Biogen MA Inc. Signed by Judge Leonard P. Stark on 7/26/17. Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Jul 24, 2017 | 6 | Motion for Leave to Appear Pro Hac Vice (14) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Sanya Sukduang, Li Feng, and Andrew E. Renison - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Jul 21, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc. for Biogen International GmbH, Biogen MA Inc. filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Jul 19, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (bkb) |
| Jul 19, 2017 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (lmm) |
| Jul 14, 2017 | 1 | Exhibit A (8) |
| Jul 14, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,399,514; 7,320,999. (lmm) |
| Jul 14, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 5, 2017. Date of Expiration of Patent: May 18, 2020, February 7, 2028.Thirty Month Stay Deadline: 9/27/2020. (lmm) |
| Jul 14, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) |
| Jul 14, 2017 | 1 | Civil Cover Sheet (4) |
| Jul 14, 2017 | 1 | Exhibit B (30) |
| Jul 14, 2017 | 1 | Complaint* (1) |
